Wall Street's biggest bear flips, $HIMS, $NVDA, $TNDM, $RKLB

Here’s the latest “under the radar” stock news from Reddit in the last 24 hours that you don’t want to miss, as picked by Fluid Bot’s AI.

Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy 

• Hims & Hers Health Inc. is offering weight-loss shots for $199 a month, undercutting big pharma competitors by as much as 85%

• The treatment has the same active ingredient as Wegovy, a drug made by Novo Nordisk A/S and Eli Lilly & Co.

• Hims & Hers Health Inc. is known for selling generic versions of popular drugs like Viagra and has almost reached $1 billion in sales

Wall Street's biggest bear flips, raises S&P 500 price target by 20% 

• Morgan Stanley's chief investment officer, Mike Wilson, raised his S&P 500 price target by 20% to 5,400 in the next 12 months

• Wilson's new target reflects about 2% upside in the index over the next 12 months

• BMO's chief investment strategist, Brian Belski, also boosted his year-end target to a street-high 5,600

• Deutsche Bank's chief equity strategist, Binky Chadha, raised his year-end target to 5,500

• Wilson sees potential upside to 6,350 in a bull case and downside to 4,200 in a bear case

• Wilson recommends a barbell approach to investing, focusing on quality growth and cyclical stocks

NVIDIA “will clearly beat expectations”  

• Analysts are optimistic about NVIDIA's performance

• NVIDIA expected to beat expectations, likely to outperform

• Nvidia (NVDA) is set to post its first-quarter earnings for the fiscal 2025 year on Tuesday, May 22nd

• Analyst believes Nvidia will outperform expectations on top-line and EPS

• Demand for Nvidia's chips is high, with expectations of strong growth

• Concerns about potential manufacturing risks from TSMC

• Expectations for AI demand to drive growth in multiple industries, including smartphones and PCs

• Predictions for a super cycle in AI devices in the fourth quarter, leading to potential stock price increases for companies like Apple, HP, Dell, Lenovo, and Samsung.

$TNDM may be getting acquired soon 

• Tandem Diabetes Care ($TNDM) likely to be acquired soon due to unexpected blackout period

• Company has 2,400 employees, blackout not related to earnings report or product release

• Insiders increased stock positions significantly, no voluntary share sales

• Blackout period suggests ongoing negotiations, possible acquisition announcement

• OP betting on $TNDM, buying calls with potential for high profit

• Biotech M&As offer high premiums, opportunity to make money with low IV

• Spread for options is poor, buying shares may be simpler

• OP discovered $TNDM through Reddit post about blackout period at company, believes acquisition is imminent

• Not financial advice, trade at own risk.

$RKLB Everybody Left as the Party Gets Started? 

• Rocket Lab (RKLB) CEO expects 50% of launches to contain their own payloads.

• Rocket Lab CEO focused on providing "services IN space".

• Starlink expected to revenue $6.6b this year.

• ASTS announces AT&T deal for direct to mobile service.

• ASTS relies on Rocket Lab for launch vehicles.

• Speculation about Rocket Lab announcing plans for broadband constellation.

• Rocket Lab considers itself "Keys to space" due to income, know-how, and launch vehicles.